Lv41
720 积分 2023-07-25 加入
PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2
3小时前
已关闭
Fibroblast growth factor receptors, developmental corruption and malignant disease
3小时前
已完结
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
14天前
已完结
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
14天前
已完结
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
14天前
已完结
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
14天前
已完结
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
14天前
已完结
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
14天前
已完结
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
14天前
已完结
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study
14天前
已完结
皖公网安备34019202002308
